Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CMMB
CMMB | US
1.61
USD-0.01
-0.62%
CMMB | US
Loading StockChartView...
About CMMB
Sector
2/12/2019
Industry
2/12/2019
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.61
Open
1.73
High
1.73
Low
1.50
Chemomab Therapeutics Ltd. a clinical-stage biotechnology company discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases. The company's lead clinical product candidate is CM-101 a humanized monoclonal antibody had completed Phase 2a clinical trials that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv Israel.
View LessCMMB | US
Risk
44.7
Sharpe
-1.06
Luna's Score
46/100
Recommendation
Hold
Luna says (CMMB | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
27.0%1 month
44.7%3 months
85.2%6 months
79.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
13.00
Price to book
2.34
Debt to equity
0.04
Debt to assets
0.02
Ent. to EBITDA
0.33
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-15.97M
MarketCap
29.80M
MarketCap(USD)
29.80M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-93.80
Short ratio
0.25
Short perc.
0.39
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.27
Range1M
0.42
Range3M
0.89
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.46
Price X volume
82.59K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.33 | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 2.34 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 85.19 | - | - |
| Debt to Equity | 0.04 | - | - |
| Debt to Assets | 0.02 | - | - |
| Market Cap | 29.80M | - | - |
